Galmed Pharmaceuticals Balance Sheet (2013-2026)

Reported Financials

Galmed Pharmaceuticals Quarterly Balance Sheet

Periods 51 quarters

Latest Jun 2026

Galmed Pharmaceuticals reported total assets of $0.02B and total liabilities of $0.01B for the quarter ended Jun 2026, down 20.3% year over year. This balance sheet covers 51 quarters of results from Dec 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	3.49M	2.88M	3.74M	1.98M	4.06M	2.02M	1.13M	1.01M	1.48M	2.86M	1.46M	1.84M	9.72M	4.65M	4.77M	5.00M	3.31M	3.99M	1.60M	2.90M
Short-term InvestmentsInvestments (Current)	38.42M	31.93M	25.00M	20.42M	15.15M	11.77M	9.73M	7.60M	9.91M	7.53M	6.72M	5.94M	6.70M	7.18M	7.42M	8.10M	8.20M	7.03M	7.77M	5.90M
Cash & Current Investments	41.91M	34.82M	28.74M	22.40M	19.21M	13.79M	10.86M	8.61M	11.39M	10.39M	8.18M	7.78M	16.42M	11.84M	12.19M	13.10M	11.51M	11.01M	9.37M	8.80M
Receivables - NetNet Receivables		1.13M				0.83M				0.48M				0.67M
Receivables - OtherOther Receivables	1.67M	1.13M	0.84M	0.61M	1.15M	0.03M	0.61M	0.34M	0.77M	0.12M	0.25M	0.14M	0.43M	0.13M	0.45M	0.43M	0.55M	0.35M	0.45M	0.32M
Receivables		2.25M				0.86M				0.60M				0.81M
Prepaid Assets														0.46M				0.27M
Current Assets	43.69M	36.05M	29.70M	23.13M	20.48M	14.72M	1.19M	9.79M	14.20M	13.24M	11.18M	10.08M	17.69M	16.12M	16.30M	21.08M	19.72M	18.63M	16.03M	11.71M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	0.15M	0.15M	0.14M	0.13M	0.12M	0.11M	0.01M	0.10M	0.09M	0.08M	0.07M			0.07M				0.06M		0.05M
Long-Term Investments						1.50M		3.27M	3.27M	3.27M	3.27M	3.27M	3.27M	2.12M	2.12M	1.59M	1.59M	0.03M		4.64M
Goodwill																				1.76M
Goodwill & Intangibles																				1.76M
Other Non-Current Assets	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.11M	0.12M	0.12M	0.12M	0.12M	0.12M	0.12M	0.26M	0.27M	0.27M	0.27M	0.12M	0.13M	0.16M
Non-Current Assets	0.61M	0.55M	0.50M	0.45M	0.39M	1.84M	1.96M	3.49M	3.44M	3.39M	3.34M	3.27M	3.27M	2.38M	2.39M	1.86M	1.86M	0.26M		6.57M
Assets	44.30M	36.61M	30.20M	23.58M	20.87M	16.56M	1.19M	13.28M	17.64M	16.63M	14.52M	13.34M	20.95M	18.50M	18.68M	22.94M	21.58M	18.63M	16.03M	18.28M
Liabilities
Current Liabilities
Accounts Payables	5.23M	4.87M	4.84M	2.09M	4.75M	2.56M	0.11M	2.14M	1.47M	1.88M	1.38M	1.20M	1.34M	1.31M	1.31M	1.37M	1.67M	2.00M	1.72M	1.90M
Payables	5.23M	4.87M	4.84M	2.09M	4.75M	2.56M	0.11M	2.14M	1.47M	1.88M	1.38M	1.20M	1.34M	1.31M	1.31M	1.37M	1.67M	2.00M	1.72M	1.90M
Other Accumulated Expenses						0.20M	0.08M			0.60M				0.50M				0.50M
Short term Debt	1.12M	1.01M	0.81M	0.64M	0.28M	0.53M	0.54M	0.58M	0.62M	0.87M	0.38M	0.35M	1.17M	0.87M	0.50M	1.05M	0.80M	0.84M	0.36M	0.83M
Current Taxes														0.32M
Current Deferred Revenue
Total Current Liabilities	6.35M	5.88M	5.65M	2.73M	5.03M	3.09M	0.18M	2.72M	2.09M	2.75M	1.77M	1.55M	2.51M	2.17M	1.81M	2.42M	2.47M	2.85M	2.08M	2.81M
Non-Current Liabilities
Capital Leases
Non-Current Debt
Convertible Debt						4.09M	4.45M							3.85M				3.73M
Non-Current Deffered Revenue
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax																				1.07M
Operating Leases	0.27M	0.23M	0.18M	0.13M	0.09M	0.04M								0.03M				0.08M		0.05M
Other Non-Current Liabilities																				1.62M
Total Non-Current Liabilities	0.27M	0.23M	0.18M	0.13M	0.09M	0.04M	5.06M			0.63M				1.67M						2.73M
Total Liabilities	6.62M	6.11M	5.83M	2.86M	-1,671.47M	3.14M	-10.80M	2.72M	-469.57M	2.75M	1.77M	1.55M	2.51M	2.17M	1.81M	2.42M	2.47M	2.85M	2.08M	5.55M
Shareholder's Equity
Total Debt	1.12M	1.01M	0.81M	0.64M	0.28M	0.53M	0.54M	0.58M	0.62M	0.87M	0.38M	0.35M	1.17M	0.87M	0.50M	1.05M	0.80M	0.84M	0.36M	0.83M
Common Equity	37.68M	30.50M	24.37M	20.71M	1,692.34M	13.42M	11.99M	10.55M	487.20M	13.88M	12.76M	11.79M	18.44M	16.33M	16.88M	20.52M	19.11M	15.78M	13.95M	12.74M
Liabilities and Shareholders Equity	44.30M	36.61M	30.20M	23.58M	20.87M	16.56M	1.19M	13.28M	17.64M	16.63M	14.52M	13.34M	20.95M	18.50M	18.68M	22.94M	21.58M	18.63M	16.03M	18.28M
Retained Earnings	-160.72M	-168.17M	-174.32M	-178.10M	-183.40M	-186.04M	-4.06M	-189.50M	-190.94M	-192.95M	-194.23M	-195.35M	-197.26M	-200.47M	-201.57M	-204.10M	-206.00M	-210.78M	-212.69M	-215.41M

Galmed Pharmaceuticals Balance Sheet API

Pull Galmed Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EOCN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "EOCN", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=EOCN&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Galmed Pharmaceuticals EOCN Balance Sheet (2013-2026)

Galmed Pharmaceuticals Quarterly Balance Sheet

Galmed Pharmaceuticals Balance Sheet API

Create an account

Sign In

Reset Password